In this
report, we indeed showed that CSCs
isolated from both 231BoM and 231BrM have strong tumor - initiating abilities; however, they preferentially metastasize to bone and brain, respectively, despite the
fact that these cells were
isolated using the same markers (CD24 − / CD44 + / ESA +).